超选择动脉插管持续热灌注化疗对卵巢晚期癌的疗效观察  

Clinical Analysis of Effects on Late Ovarian Carcinoma with Super-selective Artery Intubation Continuous Hyperthermic Chemotherapy

作　　者：朱莉[1] 李任飞[1] 

机构地区：[1]哈尔滨医科大学第四临床医学院,黑龙江哈尔滨150001

出　　处：《黑龙江医学》2009年第10期770-772,共3页Heilongjiang Medical Journal

摘　　要：目的探讨超选择动脉插管持续热灌注化疗对卵巢晚期癌的疗效。方法采用seldinger法做超选择动脉插管化疗,并对所给化疗药物给予加热至42℃,治疗卵巢晚期癌24例,其中18例伴有恶性腹水。结果18例合并腹水患者,经超选择动脉插管持续热灌注化疗治疗后,腹水基本吸收及明显减少者17例(占94.44%),自觉症状(腹痛、腹胀、下坠等)均较治疗前明显好转。治疗后,CT或B超显示,肿瘤体积缩小,粘连程度减轻,CA125下降。本组有5例卵巢晚期癌化疗后临床症状改善,但对卵巢癌晚期病人的癌症性疼痛没有明显的抑制效果。结论超选择动脉插管热化疗治疗卵巢晚期癌有效可行。Objective To observe the clinical effects of Supers elective artery intubation continuous hyperthermic chemotherapy on late ovarian carcinoma. Methods 24 patients with advanced ovarian cancer were given super- selective artery intubation chemotherapy with the method of seldinger and the drugs were heated to 42℃, in which 18 cases were accompanied with malignant ascites. Results Ascites were absorbed or significantly reduced in 17 patients after the treatment, accounting for 94.44% .Subjective symptoms （abdominal pain, abdominal distention or falling, etc. ） were obviously improved after treatment. CT or B - mode uhrasonograph： were all reduced. Five cases of advanced ovarian cancer improved y showed the tumor volume, adhesion and CA- 125 the clinical stages after chemotherapy. However, the treatment made no apparent pain inhibitor y effects on patients with late ovarian cancer. Conclusion Super-selective arterial intubation continuous hyper thermic chemotherapy on patients with advanced ovarian cancer is effective and feasible.

关 键 词：卵巢晚期癌 超选择 热化疗 

分 类 号：R815[医药卫生—放射医学] R737.31[医药卫生—临床医学]